Phase II trial combining docetaxel and doxorubicin as neoadjuvant chemotherapy in patients with operable breast cancer

Autor: Ganem, G. 1, *, Tubiana-Hulin, M. 2, Fumoleau, P. 3, Combe, M. 4, Misset, J.-L. 5, Vannetzel, J.-M. 6, Bachelot, T. 7, De Ybarlucea, L.R. 4, Lotz, V. 8, Bendahmane, B. 8, Dieras, V. 9
Zdroj: In Annals of Oncology November 2003 14(11):1623-1628
Databáze: ScienceDirect